Literature DB >> 30712302

Pregabalin misuse-related ambulance attendances in Victoria, 2012-2017: characteristics of patients and attendances.

Rose Crossin1, Debbie Scott1, Shalini Arunogiri1, Karen Smith2, Paul M Dietze3, Dan I Lubman1.   

Abstract

OBJECTIVE: To compare changes in pregabalin prescribing and misuse-related ambulance attendances; to characterise the patients attended by paramedics for pregabalin misuse-related harms; to assess the association of pregabalin misuse with use of other sedatives and with suicidal ideation and self-harm; to compare the characteristics of pregabalin misuse-related harms in people who misuse pregabalin according to whether or not they also used other sedatives. DESIGN, SETTING, PARTICIPANTS: Retrospective analysis of data on ambulance attendances in Victoria, January 2012 - December 2017, for which pregabalin misuse-related harms were a contributing factor. MAIN OUTCOME MEASURES: Rates of pregabalin misuse-related ambulance attendances, pregabalin prescription rates (each 6-monthly); patient characteristics, including age, sex, history of drug misuse or psychiatric problems, concurrent use of other sedatives, and current suicidal ideation and self-harm.
RESULTS: There were 1201 pregabalin misuse-related attendances during the study period; the rate increased from 0.28 cases per 100 000 population in the first half of 2012 to 3.32 cases per 100 000 in the second half of 2017. The attendance rate was strongly correlated with prescription rates in Australia (r = 0.90; P = 0.001). 593 attendances (49%) were for people with a history that may have contraindicated prescribing pregabalin. Pregabalin was frequently misused with other sedatives (812 attendances, 68%), particularly benzodiazepines (440, 37%); 472 attendances (39%) were associated with suicide attempts. People who misused pregabalin with other sedatives more frequently presented with moderate to severe impairments of consciousness, but the frequency of suicide attempts was similar whether other sedatives were concurrently used or not.
CONCLUSIONS: Rates of pregabalin misuse-related ambulance attendances in Victoria have increased markedly over the past 6 years. Caution is required when prescribing pregabalin for people taking other sedatives. Limiting the dispensing of this drug may reduce the risks associated with its misuse.
© 2018 AMPCo Pty Ltd.

Entities:  

Keywords:  Anticonvulsants; Drug overdose; Public health; Self-Injurious behavior; Substance-related disorders; Suicide

Mesh:

Substances:

Year:  2018        PMID: 30712302     DOI: 10.5694/mja2.12036

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  12 in total

1.  Patterns of pregabalin initiation and discontinuation after its subsidy in Australia.

Authors:  Tricia Chiu; Jonathan Brett; Sallie-Anne Pearson; Andrea L Schaffer
Journal:  Br J Clin Pharmacol       Date:  2020-03-22       Impact factor: 4.335

2.  Preliminary Evidence of Pregabalin Misuse among Prescription and/or Illicit Opioid (Mis)users.

Authors:  Mance E Buttram; Steven P Kurtz
Journal:  J Psychoactive Drugs       Date:  2020-02-27

3.  Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update.

Authors:  Kirk E Evoy; Sarvnaz Sadrameli; Jillian Contreras; Jordan R Covvey; Alyssa M Peckham; Megan D Morrison
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

4.  Healthcare expenditure and its predictors in a cohort of Australians living with sciatica.

Authors:  Alexander Chye; Chung-Wei Christine Lin; Mark J Hancock; Ian Harris; Jane Latimer; Christopher G Maher; Andrew J McLachlan; Stephanie Mathieson; Bart Koes; Richard O Day; Laurent Billot; Stephen Jan; Blake Angell
Journal:  Eur Spine J       Date:  2020-09-24       Impact factor: 3.134

Review 5.  Management of Opioid-Tolerant Patients with Acute Pain: Approaching the Challenges.

Authors:  Pamela E Macintyre; Lindy J Roberts; Christine A Huxtable
Journal:  Drugs       Date:  2020-01       Impact factor: 9.546

6.  Pregabalin poisoning and rising recreational use: a retrospective observational series.

Authors:  Katherine Z Isoardi; Gregory Polkinghorne; Keith Harris; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2020-06-05       Impact factor: 4.335

7.  Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018.

Authors:  Suzanne Nielsen; Rose Crossin; Melissa Middleton; Tina Lam; James Wilson; Debbie Scott; Catherine Martin; Karen Smith; Dan Lubman
Journal:  Addiction       Date:  2020-01-13       Impact factor: 6.526

8.  Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Australia: a protocol for a retrospective observational study.

Authors:  Suzanne Nielsen; Rose Crossin; Melissa Middleton; Catherine Martin; James Wilson; Tina Lam; Debbie Scott; Karen Smith; Dan Lubman
Journal:  BMJ Open       Date:  2019-05-27       Impact factor: 2.692

9.  Pregabalin: A range of misuse-related unanswered questions.

Authors:  Fabrizio Schifano; Stefania Chiappini
Journal:  CNS Neurosci Ther       Date:  2019-03-04       Impact factor: 5.243

10.  National Ambulance Surveillance System: A novel method using coded Australian ambulance clinical records to monitor self-harm and mental health-related morbidity.

Authors:  Dan I Lubman; Cherie Heilbronn; Rowan P Ogeil; Jessica J Killian; Sharon Matthews; Karen Smith; Emma Bosley; Rosemary Carney; Kevin McLaughlin; Alex Wilson; Matthew Eastham; Carol Shipp; Katrina Witt; Belinda Lloyd; Debbie Scott
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.